Free Trial

Singular Genomics Systems (OMIC) Insider Trading & Ownership

$16.16
+3.35 (+26.15%)
(As of 09/17/2024 ET)

Singular Genomics Systems (NASDAQ:OMIC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.20%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$103,801.80
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$2,166.50
Get OMIC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Singular Genomics Systems stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OMIC Insider Buying and Selling by Quarter

Singular Genomics Systems Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2024Andrew SpaventaCEOSell175$12.38$2,166.50  
11/16/2023Andrew SpaventaCEOBuy1,448$12.30$17,810.40  
11/16/2023Eli N GlezerInsiderBuy6,666$12.90$85,991.40  
(Data available from 1/1/2013 forward)

OMIC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Singular Genomics Systems includes Andrew Spaventa, Eli N Glezer, Kim P Kamdar, and Michael J Pellini. Learn more on insiders at OMIC.

22.20% of Singular Genomics Systems stock is owned by insiders. Learn more on OMIC's insider holdings.

The following insiders have purchased OMIC shares in the last 24 months: Andrew Spaventa ($17,810.40), and Eli N Glezer ($325,335.00).

Insiders have purchased a total of 15,446 OMIC shares in the last 24 months for a total of $343,145.40 bought.

The following insiders have sold OMIC shares in the last 24 months: Andrew Spaventa ($2,166.50), and Kim P Kamdar ($256,626.90).

Insiders have sold a total of 14,562 Singular Genomics Systems shares in the last 24 months for a total of $258,793.40 sold.



This page (NASDAQ:OMIC) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners